Molecular diagnosis of bird-mediated pest consumption in tropical farmland

por Karp, Daniel S, Judson, Seth, Daily, Gretchen C, Hadly, Elizabeth A
Publicado 2014

Landscape simplification increases vineyard pest outbreaks and insecticide use

por Paredes, Daniel, Rosenheim, Jay A., Chaplin‐Kramer, Rebecca, Winter, Silvia, Karp, Daniel S.
Publicado 2020

Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical...

por Subbiah, Ishwaria M., Tang, Chad, Rao, Arvind, Falchook, Gerald S., Subbiah, Vivek, Tsimberidou, Apostolia M., Karp, Daniel, Kurzrock, Razelle, Hong, David S.
Publicado 2018

Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours

por Karp, Daniel D., Camidge, D. Ross, Infante, Jeffery R., Ames, Tyler D., Price, Matthew R., Jimeno, José, Bryce, Alan H.
Publicado 2022

Increasing crop field size does not consistently exacerbate insect pest problems

por Rosenheim, Jay A., Cluff, Emma, Lippey, Mia K., Cass, Bodil N., Paredes, Daniel, Parsa, Soroush, Karp, Daniel S., Chaplin-Kramer, Rebecca
Publicado 2022

Reply to Marini et al.: Insect spill-over is a double-edged sword in agriculture

por Rosenheim, Jay A., Cluff, Emma, Lippey, Mia K., Cass, Bodil N., Paredes, Daniel, Parsa, Soroush, Karp, Daniel S., Chaplin-Kramer, Rebecca
Publicado 2022

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center

por Vo, Henry Hiep, Cartwright, Carrie, Song, I-Wen, Karp, Daniel D., Nogueras Gonzalez, Graciela M., Xie, Yuran, Karol, Michael, Hitron, Matthew, Vining, David, Tsimberidou, Apostolia-Maria
Publicado 2022

Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma

por DiPeri, Timothy P., Demirhan, Mehmet, Karp, Daniel D., Fu, Siqing, Hong, David S., Subbiah, Vivek, Lim, Joann, Ballester, Leomar Y., Tayar, Jean H., Suarez-Almazor, Maria E., Javle, Milind, Meric-Bernstam, Funda
Publicado 2022

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

por Dembla, Vikas, Somaiah, Neeta, Barata, Pedro, Hess, Kenneth, Fu, Siqing, Janku, Filip, Karp, Daniel D., Naing, Aung, Piha-Paul, Sarina Anne, Subbiah, Vivek, Tsimberidou, Apostolia M., Shaw, Kenna, Meric-Bernstam, Funda, Hong, David S.
Publicado 2018

Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies

por Wang, Yudong, Janku, Filip, Piha-Paul, Sarina, Hess, Kenneth, Broaddus, Russell, Liu, Lidong, Shi, Naiyi, Overman, Michael, Kopetz, Scott, Subbiah, Vivek, Naing, Aung, Hong, David, Tsimberidou, Apostolia M., Karp, Daniel, Yao, James, Fu, Siqing
Publicado 2020

Associations between the gut microbiome and fatigue in cancer patients

por Hajjar, Joud, Mendoza, Tito, Zhang, Liangliang, Fu, Siqing, Piha-Paul, Sarina A., Hong, David S., Janku, Filip, Karp, Daniel D., Ballhausen, Alexej, Gong, Jing, Zarifa, Abdulrazzak, Peterson, Christine B., Meric-Bernstam, Funda, Jenq, Robert, Naing, Aung
Publicado 2021

Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

por Sen, Shiraj, Hess, Kenneth, Hong, David S, Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Subbiah, Ishwaria M, Liu, Holly, Khanji, Rahil, Huang, Le, Moorthy, Shhyam, Karp, Daniel D, Tsimberidou, Apostolia, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2018

Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancer

por Wang, Zhijie, Piha-Paul, Sarina, Janku, Filip, Subbiah, Vivek, Shi, Naiyi, Gong, Jing, Wathoo, Chetna, Shaw, Kenna, Hess, Kenneth, Broaddus, Russell, Naing, Aung, Hong, David, Tsimberidou, Apostolia M., Karp, Daniel, Yao, James, Meric-Bernstam, Funda, Fu, Siqing
Publicado 2017

Gene methylation biomarkers in sputum as a classifier for lung cancer risk

por Leng, Shuguang, Wu, Guodong, Klinge, Donna M., Thomas, Cynthia L., Casas, Elia, Picchi, Maria A., Stidley, Christine A., Lee, Sandra J., Aisner, Seena, Siegfried, Jill M., Ramalingam, Suresh, Khuri, Fadlo R., Karp, Daniel D., Belinsky, Steven A.
Publicado 2017

Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross...

por George, Goldy C, Iwuanyanwu, Eucharia C, Buford, Adrianna S, Piha-Paul, Sarina A, Subbiah, Vivek, Fu, Siqing, Karp, Daniel D, Pant, Shubham, Hinojosa, Christina O, Hess, Kenneth R, Cleeland, Charles S, Bernstam, Elmer V, Meric-Bernstam, Funda, Hong, David S
Publicado 2019

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer

por Wang, Yudong, Wang, Zhijie, Piha-Paul, Sarina, Janku, Filip, Subbiah, Vivek, Shi, Naiyi, Hess, Kenneth, Broaddus, Russell, Shan, Baoen, Naing, Aung, Hong, David, Tsimberidou, Apostolia M., Karp, Daniel, Lu, Charles, Papadimitrakopoulou, Vali, Heymach, John, Meric-Bernstam, Funda, Fu, Siqing
Publicado 2018

Archetype models upscale understanding of natural pest control response to land‐use change

por Alexandridis, Nikolaos, Marion, Glenn, Chaplin‐Kramer, Rebecca, Dainese, Matteo, Ekroos, Johan, Grab, Heather, Jonsson, Mattias, Karp, Daniel S., Meyer, Carsten, O'Rourke, Megan E., Pontarp, Mikael, Poveda, Katja, Seppelt, Ralf, Smith, Henrik G., Walters, Richard J., Clough, Yann, Martin, Emily A.
Publicado 2022

Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors

por Dembla, Vikas, Groisberg, Roman, Hess, Ken, Fu, Siqing, Wheler, Jennifer, Hong, David S., Janku, Filip, Zinner, Ralph, Piha-Paul, Sarina Anne, Ravi, Vinod, Benjamin, Robert S., Patel, Shreyaskumar, Somaiah, Neeta, Herzog, Cynthia E., Karp, Daniel D., Roszik, Jason, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2017

Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

por Colen, Rivka R, Rolfo, Christian, Ak, Murat, Ayoub, Mira, Ahmed, Sara, Elshafeey, Nabil, Mamindla, Priyadarshini, Zinn, Pascal O, Ng, Chaan, Vikram, Raghu, Bakas, Spyridon, Peterson, Christine B, Rodon Ahnert, Jordi, Subbiah, Vivek, Karp, Daniel D, Stephen, Bettzy, Hajjar, Joud, Naing, Aung
Publicado 2021

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies

por Piha-Paul, Sarina A, Dumbrava, Ecaterina E, Nair, Binoj C, Xiong, Wendy, Xu, Li, Mostorino, Rosa, Subbiah, Vivek, Tannir, Nizar, Fu, Siqing, Naing, Aung, Janku, Filip, Karp, Daniel D, Patel, Shreyaskumar, Daw, Najat C, Hong, David, Meric-Bernstam, Funda, Zinner, Ralph
Publicado 2021